ATP8B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.982800E-01
Normal-vs-Stage2
3.114600E-01
Normal-vs-Stage3
8.362000E-01
Normal-vs-Stage4
3.065600E-01
Stage1-vs-Stage2
7.956000E-01
Stage1-vs-Stage3
3.664000E-01
Stage1-vs-Stage4
7.173400E-01
Stage2-vs-Stage3
1.706190E-01
Stage2-vs-Stage4
3.443200E-01
Stage3-vs-Stage4
1.915830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.956600E-01
Normal-vs-AfricanAmerican
2.426400E-01
Normal-vs-Asian
4.278600E-01
Caucasian-vs-AfricanAmerican
1.123810E-01
Caucasian-vs-Asian
8.602200E-01
AfricanAmerican-vs-Asian
2.097200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.625200E-01
Normal-vs-Female
3.844600E-01
Male-vs-Female
9.019400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.136200E-01
Normal-vs-Age(41-60Yrs)
3.021200E-01
Normal-vs-Age(61-80Yrs)
3.842400E-01
Normal-vs-Age(81-100Yrs)
5.603800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.593000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.258400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.043800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.661400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.960200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.492000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.886800E-01
Normal-vs-Daily Drinker
4.999400E-01
Normal-vs-Weekly Drinker
6.578800E-01
Normal-vs-Occasional Drinker
1.296210E-01
Normal-vs-Social Drinker
4.667400E-01
Non Drinker-vs-Daily Drinker
6.120000E-01
Non Drinker-vs-Weekly Drinker
3.669200E-01
Non Drinker-vs-Occasional Drinker
1.083630E-01
Non Drinker-vs-Social Drinker
8.338000E-01
Daily Drinker-vs-Weekly Drinker
6.984600E-01
Daily Drinker-vs-Occasional Drinker
7.926000E-02
Daily Drinker-vs-Social Drinker
5.883000E-01
Weekly Drinker-vs-Occasional Drinker
5.825800E-02
Weekly Drinker-vs-Social Drinker
4.496400E-01
Occasional Drinker-vs-Social Drinker
3.932400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.797570E-01
Normal-vs-Grade 2
5.342400E-02
Normal-vs-Grade 3
5.062500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.044400E-01
Grade 1-vs-Grade 3
5.751200E-01
Grade 1-vs-Grade 4
1.797570E-01
Grade 2-vs-Grade 3
2.024000E-01
Grade 2-vs-Grade 4
5.342400E-02
Grade 3-vs-Grade 4
5.062500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.526600E-01
Normal-vs-NonDiabetic
3.165800E-01
Diabetic-vs-NonDiabetic
2.155000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.851600E-01
Normal-vs-NoPancreatitis
3.893200E-01
Pancreatitis-vs-NoPancreatitis
8.443400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.798000E-01
Normal-vs-N1
2.924800E-01
N0-vs-N1
5.058000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.084600E-01
Normal-vs-TP53-NonMutant
3.170200E-01
TP53-Mutant-vs-TP53-NonMutant
7.925600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
